Suppr超能文献

腹腔镜下经前入路模块化胰脾切除术联合脾动脉前入路治疗左侧可切除胰腺癌(附视频)。

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy with Anterocranial Splenic Artery-First Approach for Left-Sided Resectable Pancreatic Cancer (with Videos).

机构信息

Department of Gastrointestinal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

出版信息

Ann Surg Oncol. 2022 Jun;29(6):3505-3514. doi: 10.1245/s10434-022-11382-x. Epub 2022 Feb 14.

Abstract

BACKGROUND

Laparoscopic radical antegrade modular pancreatosplenectomy (Lap-RAMPS) for left-sided pancreatic cancer remains a technically challenging procedure. How to approach the splenic artery in laparoscopic surgery has not been discussed in adequate detail, and the implications of an artery-first approach in left-sided pancreatic cancer remain unclear.

PATIENTS AND METHODS

Forty-five consecutive patients with left-sided resectable pancreatic cancer underwent Lap-RAMPS between July 2018 and September 2020. They were divided according to whether Lap-RAMPS was performed using an anterocranial splenic artery-first (ASF) approach (ASF group, n = 23) or via another approach (non-ASF group, n = 22). Clinical, pathological, and short-term outcomes were reviewed and compared between the groups.

RESULTS

The ASF approach was performed safely in all patients with resectable left-sided pancreatic cancer, and none required conversion to laparotomy. The ASF group had better outcomes in terms of conspicuous bleeding from the spleen during splenic mobilization (P = 0.016) and blood pooling during posterior dissection (P = 0.035). Consequently, blood loss was significantly less and operation time was significantly shorter in the ASF group than in the non-ASF group. There was no significant between-group difference in other short-term outcomes, including mortality, length of hospital stay, or Clavien-Dindo classification.

CONCLUSIONS

The ASF approach was safe when performed for resectable left-sided pancreatic cancer and may help to prevent congestion of the pancreas and lessen intraoperative blood loss.

摘要

背景

腹腔镜根治性顺行模块胰脾切除术(Lap-RAMPS)治疗左侧胰腺癌仍然是一项具有挑战性的技术操作。在腹腔镜手术中如何处理脾动脉尚未得到充分讨论,左侧胰腺癌中动脉优先入路的意义仍不清楚。

患者和方法

2018 年 7 月至 2020 年 9 月,连续 45 例左侧可切除胰腺癌患者接受 Lap-RAMPS 治疗。根据是否采用经颅前脾动脉优先(ASF)入路(ASF 组,n = 23)或其他入路(非 ASF 组,n = 22)进行 Lap-RAMPS ,将患者分为两组。回顾并比较两组患者的临床、病理和短期预后。

结果

所有可切除左侧胰腺癌患者均安全地完成了 ASF 入路,无一例需要转为开腹手术。ASF 组在脾血管游离时明显脾脏出血(P = 0.016)和后向分离时血液积聚(P = 0.035)方面的结果更好。因此,ASF 组的出血量明显少于非 ASF 组,手术时间也明显短于非 ASF 组。两组在其他短期预后方面,包括死亡率、住院时间或 Clavien-Dindo 分级,均无显著差异。

结论

对于可切除的左侧胰腺癌,ASF 入路是安全的,可能有助于预防胰腺充血和减少术中出血量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验